Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

MYSTERIOUS: Ovarian cancer - What They Never Told You

Tennis legend Chris Evert says her ovarian cancer has returned: ‘It’s relentless, but I’ll stay optimistic’

The American, 71, is a former world No 1 and 18-time grand-slam champion

The Independent UK

Ovarian cancer drug approved for NHS use will prolong lives

A drug that can treat chemotherapy-resistant ovarian cancer has just been approved for use on the NHS in England. Mirvetuximab soravtansine (also known as Elahere) is the first new drug to be approved for hard-to-treat ovarian cancer in over 20 years.

The Conversation

Oxford University and Moderna launch trials of vaccine that could prevent cancer

The jab targets patients with Lynch syndrome, who are at high risk of colorectal and ovarian cancer

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Johnson & Johnson beats lawsuit alleging that talc caused three women's cancer

A Los Angeles jury ruled in favor of Johnson & Johnson, finding the company not negligent in a lawsuit alleging its talc products caused ovarian cancer. This verdict comes as J&J faces thousands of similar claims, having previously won some cases and lost others, and having discontinued talc-based baby powder…

The Economic Times

‘Landmark’ ovarian cancer treatment approved for NHS use

IN FULL

The Independent UK

Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years

The Guardian - UK

'Significant breakthrough' as new ovarian cancer treatment approved for NHS use

A former NHS worker from north London who is taking the drug says the new treatment has let her ‘get on with my life’

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Breakthrough ovarian cancer drug that extends lives to be free on NHS for first time

Experts have hailed the ‘landmark’ decision from the National Institute for Health and Care Excellence to approve the treatment for NHS use

The Independent UK

BeOne Medicines Signals Solid Tumor Breakout as Three Programs Near Phase 3

BeOne Medicines (NASDAQ:ONC) used an investor event at ASCO to outline what executives described as a new phase of growth beyond hematology, highlighting three solid tumor programs that the company said are moving toward registrational development. John Oyler, BeOne’s co-founder, chairman and chief

MarketBeat

She fainted in school from period pain for years; now the 27-year-old fights stage 4 cancer alone after losing her father, with no siblings by her side

Radhika Sapra endured years of dismissed menstrual pain, only to be diagnosed with stage 4 ovarian cancer at 22. Now 27, she battles the disease and financial hardship, a journey marked by childhood abuse and abandonment. She lost her father in 2022 and has no siblings. Despite immense challenges, she…

The Economic Times

Compugen Q1 Earnings Call Highlights

Compugen (NASDAQ:CGEN) said it remains on track to report interim progression-free survival data in the first quarter of 2027 from its MAIA-ovarian study, as the clinical-stage immuno-oncology company outlined first-quarter 2026 results and updates across its internal and partnered programs. On the

MarketBeat

7 Early Cancer Signs Most People Ignore

Cancer often begins quietly, making its early signs easy to overlook. A little fatigue, unusual swelling, constant bloating, or pain that refuses to fade may seem like ordinary health issues at first. That is what makes early cancer symptoms so dangerous they often appear normal until they slowly become serious.…

MyLifeXP

Researchers warn of key new driver of 11 cancers in under-50s – and it’s not smoking or poor diet

A new study has found that 11 types of cancer are on the rise in the 20 to 49-year-old age group

The Independent UK

Drug for rare disease could be used to extend lives of ovarian cancer patients, study finds

Patients with a certain type of ovarian cancer could benefit by taking a drug for Cushing’s syndrome

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant cases

The Independent UK

Landmark tumour mapping research could boost targeted breast and ovarian cancer therapies

The researchers said the findings indicate many more patients may benefit from precision therapies

The Guardian - AU

Rhoda Roberts, Indigenous cultural leader who introduced the term ‘welcome to country’, dies aged 66

Roberts, who was the first Aboriginal person to host a prime-time current affairs program, was diagnosed with a rare type of ovarian cancer seven months ago

The Conversation

What’s the link between talcum powder and cancer?

More than 1,300 Victorians have joined a class action against Johnson & Johnson alleging its talcum powder products left them with ovarian cancer, mesothelioma (cancer affecting the lungs) and other cancers affecting the reproductive organs.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Earlier diagnosis of ovarian cancer possible with medical tampon, research suggests

Currently more than 50 per cent of women are diagnosed with ovarian cancer at an advanced stage when fewer treatment options are available

The Independent UK

Am I more likely to get ovarian cancer as I get older?

Age is the primary risk factor for ovarian cancer.

The Independent UK

Elle Simone Scott, trailblazing America’s Test Kitchen chef, dies aged 49

Celebrity chef died from ovarian cancer

The Independent UK

Johnson & Johnson ordered to pay women over talcum powder cancer cases

The healthcare giant immediately announced its intention to appeal the liability verdict and compensatory damages

AAP

Burden of a deadly cancer hitting women in their prime

Ovarian cancer is one of the deadliest diseases affecting Australian women and also causes a significant economic burden.

AAP

Women's voices amplify push for ovarian cancer test

Women in hospitality have gathered to support one of their own and raise funds for vital research on an early detection test for ovarian cancer.

The Independent UK

CNN host Christiane Amanpour battling cancer again and urges people to ‘listen to their bodies’

Journalist has spoken about recurrence of ovarian cancer, four years after initial diagnosis

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Oxford

The Institute of Cancer Research

55 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.